Emergent BioSolutions (EBS) Divestments (2023)
Emergent BioSolutions (EBS) posted quarterly Divestments of $74.9 million for Q2 2023.
Emergent BioSolutions (EBS) Divestments (2023) Analysis & Trends
Emergent BioSolutions' Divestments history runs 1 years deep, the most recent figure standing at $74.9 million for Q2 2023.
- In Q2 2023, Divestments changed N/A year-over-year to $74.9 million; the TTM figure through Dec 2024 stood at $74.9 million (changed 0.0% YoY), while the FY2024 annual figure was $110.2 million, down 59.22% from the prior year.
- Divestments for Q2 2023 stood at $74.9 million.
- The five-year high for Divestments was $74.9 million in Q2 2023, with the low at $74.9 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 74.90 Mn |